Patent details

EP3641888 Title: PLASMINOGEN TREATMENT OF CONDITIONS ASSOCIATED WITH PAI-1 OVEREXPRESSION

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3641888
WO Application Number:
IB2018000655
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP18821458.9
WO Publication Number:
WO2018234861
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
22/06/2018
Grant date:
11/10/2023
EP Publication Date:
29/04/2020
WO Publication Date:
27/12/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
19/12/2023
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
11/10/2023
EP B1 Publication Date:
11/10/2023
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
21/06/2038
Lapsed By Expiration Date:
Patent Validated Date:
04/01/2024
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
01/02/2024
 
 

 

Name:
Kedrion Biopharma Inc.
Address:
400 Kelby Street, 11th Floor, 07024, Fort Lee, NJ, United States of America (US)

Historical Applicant/holder

From:
11/10/2023
To:
01/02/2024

 

Name:
Prometic Bio Therapeutics, Inc.
Address:
1330 Piccard Drive Suite 201, Rockville, MD 20850, United States of America (US)

Inventor

1

Name:
GAGNON, Lyne
Address:
Laval, Quebec H7M 3E5, Canada (CA)

2

Name:
GROUIX, Brigitte
Address:
Montréal, Québec H2B 1H2, Canada (CA)

3

Name:
LAURIN, Pierre
Address:
Ville Mont-Royal, Quebec H3R 2Y6, Canada (CA)

Priority

Priority Patent Number:
201762523901 P
Priority Date:
23/06/2017
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 38/48; A61P 3/00; A61P 7/02; A61P 9/00; A61P 17/02; A61P 29/00;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
06/24
Publication date:
07/02/2024
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
02/24
Publication date:
10/01/2024
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
41/23
Publication date:
11/10/2023
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202341
Publication date:
11/10/2023
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC202400233A
Date Registered:
01/02/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Y.R. Hernandez
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Kedrion Biopharma Inc.
Address:
400 Kelby Street, 11th Floor, 07024, Fort Lee, NJ, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/06/2026
Annual Fee Number:
9
Annual Fee Amount:
340 Euro
Last Annual Payment Date:
20/05/2025
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
280 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
03/01/2024 Outgoing Correspondence Letter no formal defects 1 PDF /8/6/6/0/3/0800930668/docs/ep18821458.9_1_583970l271.pdf
19/12/2023 Claims First filed claims 2 PDF /8/6/6/0/3/0800930668/docs/ep18821458.9_0_claims20231219184509329.pdf